Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

C16 Dihydrosphingomyelin is a sphingolipid and saturated form of C16 sphingomyelin (Item No. 10007946). It is the most abundant phospholipid in the human lens and redistributes to the barrier region with increasing age, and serum levels of C16 dihydrosphingomyelin are decreased in patients with chronic migraine.1,2 C16 Dihydrosphingomyelin has been used as a helper lipid in the generation of liposomal lipid nanoparticles (LNPs) for the delivery of mRNA in vitro and in vivo.3 Incorporation of C16 dihydrosphingomyelin into liposomal LNPs increases blood circulation half-life and improves extrahepatic distribution and transfection in mice compared with liposomal LNPs containing egg sphingomyelin (ESM; Item No. 24345).
WARNING This product is not for human or veterinary use.
1. Sphingolipid distribution changes with age in the human lens. J. Lipid Res. 51(9), 2753-2760 (2010).
2. Elevated serum levels of acid sphingomyelinase in female patients with episodic and chronic migraine. Antioxidants (Basel) 14(2), 159 (2025).
3. Liposomal lipid nanoparticles containing dihydrosphingomyelin exhibit improved stability and extended hepatic and extrahepatic transfection. J. Control Release 396, 115098 (2026).